| Product Code: ETC8889567 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal NGS Based Molecular Diagnostic Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal NGS Based Molecular Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal NGS Based Molecular Diagnostic Market - Industry Life Cycle |
3.4 Portugal NGS Based Molecular Diagnostic Market - Porter's Five Forces |
3.5 Portugal NGS Based Molecular Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Portugal NGS Based Molecular Diagnostic Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Portugal NGS Based Molecular Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in Portugal |
4.2.2 Growing demand for personalized medicine and precision healthcare |
4.2.3 Technological advancements in Next-Generation Sequencing (NGS) technologies |
4.2.4 Favorable government initiatives and funding for molecular diagnostics |
4.2.5 Rising awareness among healthcare professionals and patients about the benefits of NGS-based molecular diagnostics |
4.3 Market Restraints |
4.3.1 High costs associated with NGS-based molecular diagnostic tests |
4.3.2 Data security and privacy concerns related to genetic information |
4.3.3 Lack of skilled professionals in the field of NGS-based molecular diagnostics |
4.3.4 Regulatory challenges and uncertainties in the approval process for NGS-based tests |
4.3.5 Limited reimbursement policies for NGS-based molecular diagnostic procedures |
5 Portugal NGS Based Molecular Diagnostic Market Trends |
6 Portugal NGS Based Molecular Diagnostic Market, By Types |
6.1 Portugal NGS Based Molecular Diagnostic Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Portugal NGS Based Molecular Diagnostic Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Portugal NGS Based Molecular Diagnostic Market Revenues & Volume, By Microbiology, 2021- 2031F |
6.1.4 Portugal NGS Based Molecular Diagnostic Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.1.5 Portugal NGS Based Molecular Diagnostic Market Revenues & Volume, By Oncology, 2021- 2031F |
6.1.6 Portugal NGS Based Molecular Diagnostic Market Revenues & Volume, By Genetic Tests, 2021- 2031F |
6.1.7 Portugal NGS Based Molecular Diagnostic Market Revenues & Volume, By Other Applications, 2021- 2031F |
6.2 Portugal NGS Based Molecular Diagnostic Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 Portugal NGS Based Molecular Diagnostic Market Revenues & Volume, By Research Centres and Academics, 2021- 2031F |
6.2.3 Portugal NGS Based Molecular Diagnostic Market Revenues & Volume, By Hospitals and Clinical Laboratories, 2021- 2031F |
6.2.4 Portugal NGS Based Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
7 Portugal NGS Based Molecular Diagnostic Market Import-Export Trade Statistics |
7.1 Portugal NGS Based Molecular Diagnostic Market Export to Major Countries |
7.2 Portugal NGS Based Molecular Diagnostic Market Imports from Major Countries |
8 Portugal NGS Based Molecular Diagnostic Market Key Performance Indicators |
8.1 Average turnaround time for NGS-based molecular diagnostic tests |
8.2 Rate of adoption of NGS-based molecular diagnostics in clinical settings |
8.3 Number of research collaborations and partnerships in the NGS molecular diagnostic market |
8.4 Percentage of healthcare facilities offering NGS-based molecular diagnostic services |
8.5 Patient satisfaction scores related to NGS-based molecular diagnostic testing experience |
9 Portugal NGS Based Molecular Diagnostic Market - Opportunity Assessment |
9.1 Portugal NGS Based Molecular Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Portugal NGS Based Molecular Diagnostic Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Portugal NGS Based Molecular Diagnostic Market - Competitive Landscape |
10.1 Portugal NGS Based Molecular Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Portugal NGS Based Molecular Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here